Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 260-828-5 | CAS number: 57583-34-3
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Toxicity to reproduction: other studies
Administrative data
- Endpoint:
- toxicity to reproduction: other studies
- Type of information:
- migrated information: read-across based on grouping of substances (category approach)
- Adequacy of study:
- key study
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- other: see 'Remark'
- Remarks:
- Guideline study conducted under GLP. Preferred study for this SIDS endpoint. The method of analysis involved derivatization. This method only measures the amount of the alkyltin moiety, MMT, present and does not identify the other ligands attached to the tin. Currently there is no analytical method available that can quantify the actual named substance, i.e., the entire organotin compound with its associated chloride ligand.
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 004
- Report date:
- 2004
Materials and methods
Test guideline
- Qualifier:
- according to guideline
- Guideline:
- other: OECD 421
- GLP compliance:
- yes
- Type of method:
- in vivo
Test material
- Reference substance name:
- 213-60-8
- IUPAC Name:
- 213-60-8
- Reference substance name:
- Trichloromethylstannane
- EC Number:
- 213-608-8
- EC Name:
- Trichloromethylstannane
- Cas Number:
- 993-16-8
- Molecular formula:
- CH3Cl3Sn
- IUPAC Name:
- (trichloromethyl)stannane
- Details on test material:
- - Name of test material (as cited in study report): Trichloromethylstannane
- Molecular formula (if other than submission substance): CH3Cl3Sn
- Molecular weight (if other than submission substance): 240.8 g/mol
- Smiles notation (if other than submission substance): Cl[Sn](Cl)(Cl)C
- InChl (if other than submission substance): IUPAC : Stannane, trichloromethyl
- Structural formula attached as image file (if other than submission substance): see Fig.
- Physical state: liquid
- Analytical purity: 82.85%
- Impurities (identity and concentrations):
- Composition of test material, percentage of components:
Alkyl group distribution % (mass/mass)
Monomethyltin trichloride 82.85
Dimethyltin dichloride 9.29
Trimethyltin chloride 0.02
Tin tetrachloride 4.68
Me2ClSnCH2SnCl3 0.59
MeCl2SnCH2SnCl3 1.78
Cl3SnCH2SnCl3 0.80
- Lot/batch No.: 82420
- Expiration date of the lot/batch: December 1, 2003
- Storage condition of test material: <-18 deg C, in the dark
Constituent 1
Constituent 2
Test animals
- Species:
- rat
- Strain:
- Wistar
- Sex:
- female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: Charles River Deutschland, Sulzfeld, Germany.
- Age at study initiation: (P) x 15-16 weeks; (F1) x wks
- Weight at study initiation: (P) Males: 113.9 - 13.8 g (mean 126.3g); Females: 178.8 - 213.5 g (mean 199.7 g); (F1) Males: x-x g; Females: x-x g
- Fasting period before study: not reported
- Housing: 3 or 4 per group per cage; during gestation and lactation they w ere housed individually
- Use of restrainers for preventing ingestion (if dermal): not applicable
- Diet (e.g. ad libitum): ad libitum
- Water (e.g. ad libitum): ad libitum
- Acclimation period: 13 days
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 22 +/- 3 deg C
- Humidity (%): 30% not exceeding 70%
- Air changes (per hr): 10
- Photoperiod (hrs dark / hrs light): 12 hours light/ 12 hours dark
IN-LIFE DATES: From: May 20, 2003 To: June 26- July 14, 2003
Administration / exposure
- Route of administration:
- oral: feed
- Vehicle:
- unchanged (no vehicle)
- Details on exposure:
- PREPARATION OF DOSING SOLUTIONS: The test substance was incorporated into the basal diet by mixing in a mechanial blender
DIET PREPARATION
- Rate of preparation of diet (frequency): shortly before the start of the studies and every 6 weeks thereafter
- Mixing appropriate amounts with (Type of food): Rat and Mouse No. 3 Breeding Diet, RM3
- Storage temperature of food: stored in a freezer until use
VEHICLE- no vehicle - Analytical verification of doses or concentrations:
- yes
- Details on analytical verification of doses or concentrations:
- ANALYTICAL METHODS: GC-MS was used to determine the achieved concentration, homogeneous distribution and stability of the test substance in diet samples. The method of analysis involved derivatization. This method only measures the amount of the alkyltin moiety, MMT, present and does not identify the other ligands attached to the tin. Currently there is no analytical method available that can quantify the actual named substance, i.e., the entire organotin compound with its associated chloride ligand.
From each diet sample, 2.0 g was transferred into a 50 mL Greiner tube. An aliquot of the internal standard solution was added. Subsequently, methanol, acetate buffer solution, 20% aqueous NaBEt4 solution and hexane were added to each sample and this mixture was shaken and heated to 60 deg C. Prior to GC/MS analysis, the hexane layer was washed with 2 mol/l HCl in order to remove the ethylboron compounds. The concentration of each test substance in feed was determined by GC-MS analysis of the hexane extracts. - Duration of treatment / exposure:
- 2 consecutive weeks during the premating period, daily during gestation (up to 26 days) and up to euthanasia at or shortly after postnatal day (PN 4)
- Frequency of treatment:
- daily
- Duration of test:
- 13-week
Doses / concentrations
- Remarks:
- Doses / Concentrations:
30, 150, 750 mg trichloromethylstannane/kg diet
Basis:
nominal in diet
- No. of animals per sex per dose:
- 10 females per dose level for satellite group
- Control animals:
- yes, concurrent no treatment
- Details on study design:
- The test substance was administered at constant concentrations in the diet for 13 consecutive weeks. The test substance was administered via the diet two weeks premating, during gestation and up to euthanasia at or shortly after postnatal day 4.
- Statistics:
- - Test substance analysis: Homogeneity: one way analysis of variance (Anova) using the sample location (1-5) as grouping factor. The test substance was considered to be homogeneously distributed in the diets if p > 0.01 and/or if the relative standard deviation (RSD) between the sample means was less than or equal to 15%. Stability: one way analysis of variance (Anova) using time as grouping factor. The test substance was considered to be stable in the diets if p > 0.01 and/or if the mean concentration on the last day was between 80% and 120% of the mean concentration on the first day (t =0). Achieved concentration: for each concentration level, the mean of the concentrations, as measured in the diet samples used for the assessment of the homogeneity, was considered to represent the achieved concentration. The content of the test substance in the diet was considered to be 'close to intended' if the mean measured concentration was between 80% and 120% of the intended concentration. - Body weight: one way analysis of covariance (covariate: body weight on day 0) followed by Dunnett's multiple comparison tests. - Food consumption and food efficiency: one way analysis of variance (Anova) followed by L.S.D. tests. - Fisher's exact probability test was used to evaluate the number of mated and pregnant females and females with live pups. Number of implantation sites, live and dead pups were evaluated by Kruskal-Wallis non-parametric analysis of variance followed by the Mann-Whitney U-test. - The litter was used as the statistical unit for calculation of fetal values. - Histopathological changes: Fisher's exact probability test. All tests were two-sided. Probability values of p<0.05 were considered significant.
Results and discussion
Effect levels
open allclose all
- Dose descriptor:
- NOAEL
- Effect level:
- 750 mg/kg diet
- Sex:
- male/female
- Basis for effect level:
- other: Based on the absence of statistically significant reproductive or developmental effects observed after mating of females of the 750 mg/kg satellite group with male animals of the main study,(= 49.7 mg/kg bw/day in males and 26.5 - 45.8 mg/kg females)
- Dose descriptor:
- NOAEL
- Effect level:
- 150 mg/kg diet
- Sex:
- male/female
- Basis for effect level:
- other: Based on the incidences of missing pups in the 750 mg/kg group
- Dose descriptor:
- NOAEL
- Effect level:
- 150 mg/kg diet
- Sex:
- female
- Basis for effect level:
- other: Based on the effects observed on body weight and food consumption in the 750 mg/kg group, 150 mg/kg diet (equivalent to 6.2 - 11.7 mg MMTC/kg bw/day in females)
Observed effects
NOAEL (postnatal toxicity): 150 mg test substance/kg diet
NOAEL (maternal toxicity): 150 mg test substance/kg diet
Any other information on results incl. tables
The test substance intake of the female animals of the 30, 150 and 750 mg/kg dose groups was respectively:
Premating period
days 0-7: 1.8, 9.0 and 44.5 mg/kg bw/day
days 7-14: 1.8, 8.8 and 43.9 mg/kg bw/day
Gestation period
GD 0-7: 1.9, 9.6 and 44.5 mg/kg bw/day
GD 7-14: 2.0, 9.6 and 45.8 mg/kg bw/day
GD 14-21: 1.2, 6.2 and 35.9 mg/kg bw/day
Lactation period
PN 1-4: 1.7, 11.7 and 26.5 mg/kg bw/day
Analysis of the test substance in diet samples revealed that the test substance dose was close to the nominal level for all diets. Mean measured concentrations ranged from 96 to 113% of nominal concentrations.
Homogeneity: The test substance was considered to be homogenously distributed in all diets.
Stability: The test substance was considered to be stable in the diets upon storage at room temperature for 7 days, and upon storage at < -18°C for 6 weeks.
MATERNAL TOXIC EFFECTS:
- Mortality and day of death: One animal of the 750 mg/kg group was found dead on GD 22 (i.e. 37 days after the start of exposure).
- Pre-coital time: comparable among the control and the treated groups.
- Mating index: 90 -100%
- Number of pregnant females per dose level: 9, 8, 9 and 8 for the control, 30, 150 and 750 mg/kg groups, respectively.
- Female fecundity index: comparable among the control and the treated groups.
- Female fertility index: comparable among the control and the treated groups.
- Male fertility index: comparable among the control and the treated groups.
- Number aborting: No data available.
- Number of resorptions: No data available.
- Mean number of implantations: 11.2 (control group), 10.8 (30 mg/kg), 11.6 (150 mg/kg), 10.5 (750 mg/kg).
- Gestation index: 89, 100, 100 and 88% in the control, 30, 150 and 750 mg/kg groups, respectively.
- Live birth index: 98, 97, 100 and 96% in the control, 30, 150 and 750 mg/kg groups, respectively.
- Number of pups born (number of litters): 90(8), 86(8), 99(9) and 50(7) for the control, 30, 150 and 750 mg/kg groups, respectively.
- Number of stillborn pups (number of litters): 2(1), 3(2), 0 and 2(2) for the control, 30, 150 and 750 mg/kg groups, respectively.
- Post implantation losses [total implantation sites minus total live births at the first observation]: 13(18.6%), 16(15.3%), 5(4.7%) and 36(42.9%) for the control, 30, 150 and 750 mg/kg groups, respectively.
Interpretation of these data was complicated by the incidence of missing pups across groups. A variable incidence of pups "missing" after birth was recorded. The incidence of missing pups was statistically significantly higher than controls in the high-dose group, statistically significantly lower than controls in the mid-dose group, and not statistically different than controls in the low-dose group. The missing pups were presumed to have been cannibalized by the dams, but it is not known if the missing pups were alive or dead. It is also not known if some pups were cannabilized prior to being counted for litter size. This could account for the slightly lower number of recorded live births and the slightly higher post-implantation loss in the high-dose versus controls.
The reason for missing pups can not be determined on the basis of the data within the study. Missing pups could be due soley to a toxic behavioral effect on dams which caused a lack of, or abnormal, nurturing. It is clear that no malformations were noted at any observation point for any of the missing pups and no overt behavioral effects were noted, however some other effect could have caused the dam to eat them.
- Number of corpora lutea: No data available.
- Duration of Pregnancy: 21 -23 days
- Body weight: Increased body weight change from GD 7-14 of the females of the 30 mg/kg group, which was considered a chance finding. Mean body weights (change) of the females were similar among the control, 30 and 150 mg/kg group during the entire study.
Mean body weight (changes) between PN 1-4 of the 750 mg/kg group was decreased; however, no statistical significance was reached for these findings.
- Food consumption: Food consumption of the female animals of the 750 mg/kg group was decreased (not statistically significantly) during the lactation period. During the premating and gestation periods food consumption of the females was similar in the control, 30, 150 and 750 mg/kg groups.
- Description, severity, time of onset and duration of clinical signs: No data available.
- Hematological findings incidence and severity: No data available.
- Clinical biochemistry findings incidence and severity: No data available.
- Gross pathology incidence and severity: No treatment related changes were observed. The animal found dead on day 37 was necropsied. Findings included yellow patches on the liver, yellow appearance of the small intestines, haemorrhagic discharge from the vagina and a haemothorax. The haemothorax was considered to be the probable cause of death. Most probably the haemothorax was caused by severe dystocia, since at necropsy the uterus contained 12 dead fetuses.
- Organ weight changes: Mean absolute and relative uterus, ovary and thymus weights were similar in all groups.
- Histopathology incidence and severity: No treatment related histopathological changes were observed in the uterus, ovary and thymus of the female animals of the control and 750 mg/kg groups.
FETAL DATA:
- Litter size: The mean number of pups delivered per litter amounted to 11.2, 10.8, 11.0 and 7.1 for the control, 30, 150 and 750 mg/kg groups, respectively.
- Litter weight: The mean pup weights and pup weight changes were similar in the treated groups when compared to the control group.
- Pup mortality: 2.2, 3.5, 0 and 4% for the control, 30, 150 and 750 mg/kg groups, respectively (PN 1); 16, 25, 3 and 65% for the control, 30, 150 and 750 mg/kg groups, respectively (PN 4).
- Number viable: The viability index (PN 1-4) was 84, 75, 97 and 35% in the control, 30, 150 and 750 mg/kg groups, respectively.
- Number live pups per litter: 11.0, 10.4, 11.0 and 6.9 for the control, 30, 150 and 750 mg/kg groups, respectively (PN 1); 10.6, 7.8, 10.7 and 4.2 for the control, 30, 150 and 750 mg/kg groups, respectively (PN 4).
- Sex ratio: No difference was observed in the sex ratio between the groups.
- Postnatal growth: No data available; screening study.
- Postnatal survival: No data available; screening study.
- Grossly visible abnormalities: In the 30 mg/kg group, the number of cold pups was statistically significantly increased on PN 1 and 4. In addition on PN 4, the number of runts, pale pups and pups with no milk in the stomach was statistically significantly increased in the 30 mg/kg group. In the 150 mg/kg group the number of pale pups on PN 4 was statistically significantly increased. In the 750 mg/kg group the number of cold pups was statistically significantly increased on PN 1. As most effects were observed in the 30 mg/kg group only, these effects were not considered to be treatment related. Macroscopic observation of the stillborn pups revealed no abnormalities of the pups.
- External abnormalities: No data available; screening study.
- Soft tissue abnormalities: No data available; screening study.
- Skeletal abnormalities: No data available; screening study.
Applicant's summary and conclusion
- Executive summary:
The toxicity of trichloromethylstannane [CAS # 993-16-8] in Wistar rats was examined using continuous administration via the diet for 13 consecutive weeks (OECD Test Guideline 408). In satellite groups of female rats a reproduction/developmental screening test (OECD Test Guideline 421) was performed to provide initial data on possible reproductive and developmental effects of trichloromethylstannane. The main study used four groups of 10 rats/sex (13 -week study) and the satellite study used four groups of 10 female rats (reproduction/developmental screening study). For both studies the control group was kept on control diet and three test groups received experimental diets containing 30, 150 and 750 mg/kg [ppm] of the test substance. The dose levels used in both studies were based on the results of a preceding dose range finding study.
In the satellite study female rats were fed their respective test diets beginning 2 weeks prior to the mating period, and continued on test diets through mating, gestation, and up to PN 4 or shortly thereafter. Male rats from the main study were mated after a premating period of 10 weeks with female rats of the satellite groups which were fed the same dose of test diets.
Clinical observations, growth, food consumption, food conversion efficiency, neurobehavioural testing, ophthalmoscopy, haematology, clinical chemistry, renal concentration test, urinalysis, organ weights and gross examination at necropsy, microscopic examination of various organs and tissues and assessment of various reproductive and developmental parameters were used as criteria for detecting the effects of treatment.
Results
Satellite study – Reproduction/developmental screening study OECD Test Guideline421
The calculated doses during the pre-mating, gestation and lactation periods for the females receiving 30, 150, or 750 mg/kg trichloromethylstannane in the diet ranged from 1.2-2.0, 6.2-11.7 and 26.5-45.8 mg/kg body weight, respectively.
During the study one animal of the 750 mg/kg group was found dead on GD22. Most probably haemothorax caused by dystocia was the cause of death. No other mortalities or treatment-related clinical signs were observed in the female animals of the satellite groups.
Mean body weight, body weight change and food consumption was similar in the control and the 30 and 150 mg/kg groups. Mean body weight on PN 4 and mean body weight change PN 1-4 of the 750 mg/kg group was decreased, although not statistically significantly.
During the premating and gestation periods, mean food consumption of the female animals was similar in the control, 30 and 150 mg/kg groups. During the lactation period food consumption of the 750 mg/kg group was decreased (not statistically significantly).
No treatment-related effects on reproduction and development of the pups were observed in the 30 and 150 mg/kg groups.
In the 750 mg/kg group, a number of changes were seen, indicative of a reproductive and developmental effect. One animal was found dead on GD22 (death was most probably caused by haemothorax caused by dystocia), post-implantation loss was 43%, the number of pups delivered was 7.1 versus 11.2 in the control group, 3 females lost all pups between PN 1-4, and pup mortality between PN 1-4 in the 750 mg/kg group was 65% versus 16% in the control group.
No treatment-related effects on pup weight and pup abnormalities were observed.
Absolute and relative organ weights (uterus, ovary and thymus) were similar among the groups. At microscopic examination of these organs no treatment-related histopathological changes were observed.
Conclusions
Satellite study - Reproduction/developmental screening study (OECD Test Guideline 421)
Based on reproductive and developmental effects (decreased number of pups delivered and increased post implantation loss and pup mortality) observed after mating of female animals of the 750 mg/kg satellite group with male animals of the main study, the mid-dose level 150 mg Trichloromethylstannane/kg diet (equivalent to 9.8 mg/ kg body weight/day in males and 6.2-11.7
mg/kg body weight for females) can be considered as a NOAEL for fertility and developmental
effects.
Based on the effects on body weight and food consumption in the 750 mg/kg group, 150 mg
Trichloromethylstannanel kg diet (equivalent to 6.2-11.7 mg/kg body weight/day) can be considered as a NOAEL for maternal toxicity.
Qverall conclusion:
The NOAEL for general sub-chronic toxicity and maternal toxicity, fertility and developmental effects was placed at 150 mg trichloromethylstannane per kg diet.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.